Charlene McEvoy is a Respiratory physician affiliated with HealthPartners. OpenAlex indexes 111 publications with 8,409 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
401 Phalen Blvd
Mail Stop 41102d
Saint Paul, MN 551015302
Telephone
651-254-7670Registry record last updated 26 Aug 2015.
Clinical trials
- Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
Sponsor: HealthPartners Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- 3B Medical, Inc.Program year20251 payment
- Philips North America LLCProgram year20251 payment
- Itamar Medical IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
59.6%Corticosteroid37.3%Budesonide-Formoterol Fumarate30%Dulera19%Fluticasone Propionate10%Symbicort9%Breyna7%Asmanex Hfa5%Trelegy Ellipta5%Breztri Aerosphere4%Pulmicort Flexhaler3%Breo Ellipta3%Asmanex2%Qvar Redihaler2%Qnasl2%Part D<11 patientsLeukotriene Receptor Antagonist9.1%Montelukast Sodium100%Part D≥71 patients+ 5 more classes in this area
Metabolism & gastrointestinal
21.2%Corticosteroid8.7%Prednisone100%Part D≥99 patientsH2 blocker7.3%Famotidine100%Part D≥59 patients+ 2 more classes in this area
Anti-infectives
13.5%Macrolide Antimicrobial6.2%Azithromycin100%Part D≥54 patientsTetracycline-class Drug6.1%Doxycycline Monohydrate91%Doxycycline Hyclate9%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025
MMWR Morbidity and Mortality Weekly Report
2025 - Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025
MMWR Morbidity and Mortality Weekly Report
2025 - Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
MMWR Morbidity and Mortality Weekly Report
2024 - Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
MMWR Morbidity and Mortality Weekly Report
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Kottke, MD
HealthPartners
Amy Criego, MD
HealthPartners
David Niccum, MD
HealthPartners
Branden Duffey, DO
HealthPartners
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”